Thomas E Lew

19PUBLICATIONS
85CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 09, 2026
The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

|Sep 02, 2026
MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

|Jul 29, 2026
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

|Jul 24, 2026
Long-term outcomes with continuous venetoclax for relapsed chronic lymphocytic leukemia.

|Mar 05, 2025
Differential regulation of BAX and BAK apoptotic activity revealed by small molecules.

Kaiming Li, Yu Q Yap, Donia M Moujalled

|Oct 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia.

Meng-Xiao Luo, Tania Tan, Marie Trussart

Pageof 4

Frequent Collaborators

12 joint publications

John F Seymour

8 joint publications

Constantine S Tam

7 joint publications

David Ching Siang Huang

7 joint publications

Andrew W Roberts